The small cell lung cancer-specific isoform of RE1-silencing transcription factor (REST) is regulated by neural-specific Ser/Arg repeat-related protein of 100 kDa (nSR100)

Molecular Cancer Research

Volumn 11, Issue 10, 2013, Pages 1258-1268

  Shimojo, Masahito ^a   Shudo, Yoshie ^a   Ikeda, Masatoshi ^a   Kobashi, Tomoyo ^a   Ito, Seiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ISOPROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; NEUROTRANSMITTER; NEUROTRANSMITTER RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN NSR100; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REST; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; NERVE PROTEIN; NSR100 PROTEIN, MOUSE; RE1-SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; CARCINOGENICITY; CONTROLLED STUDY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ALTERNATIVE RNA SPLICING; ANIMAL; BAGG ALBINO MOUSE; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; SMALL CELL LUNG CANCER; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84886398684     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-13-0269     Document Type: Article

References (34)

1. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002;64:681-708.
2. Wistuba II, Gazdar AF, Minna JD. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001;28:3-13.
3. Lung Cancer Facts. Available from: [Lung Cancer Research Foundation (LCRF), http://www. lungfund. org/lung-cancer-facts. htm].
4. Aisner J. Extensive-disease small-cell lung cancer: the thrill of victory; the agony of defeat. J Clin Oncol 1996;14:658-65.
5. Kraus AC, Ferber I, Bachmann SO, Specht H, Wimmel A, Gross MW, et al. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene 2002;21:8683-95.
6. Martínez-García E, Irigoyen M, Gonzalez-Moreno O, Corrales L, Teijeira A, Salvo E, et al. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment. Toxicol Sci 2010;116:467-76.
7. Chong JA, Tapia-Ramirez J, Kim S, Toledo-Aral JJ, Zheng Y, Boutros MC, et al. REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 1995;80:949-57.
8. Schoenherr CJ, Anderson DJ. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 1995;267:1360-3.
9. Coulson JM. Transcriptional regulation: cancer, neurons and the REST. Curr Biol 2005;15:R665-8.
10. Majumder S. REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 2006;5:1929-35.
11. Mandel G, Fiondella CG, Covey MV, Lu DD, Loturco JJ, Ballas N. Repressor element 1 silencing transcription factor (REST) controls radial migration and temporal neuronal specification during neocortical development. Proc Natl Acad Sci USA 2011;108: 16789-94.
12. Schoenherr CJ, Paquette AJ, Anderson DJ. Identification of potential target genes for the neuron-restrictive silencer factor. Proc Natl Acad Sci USA 1996;93:9881-6.
13. Schoch S, Cibelli G, Thiel G. Neuron-specific gene expression of synapsin I. Major role of a negative regulatory mechanism. J Biol Chem 1996;271:3317-23.
14. Bruce AW, Donaldson IJ, Wood IC, Yerbury SA, Sadowski MI, Chapman M, et al. Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc Natl Acad Sci USA 2004;101:10458-63.
15. Lunyak VV, Rosenfeld MG. No rest for REST: REST/NRSF regulation of neurogenesis. Cell 2005;121:499-501.
16. Shimojo M, Hersh LB. REST/NRSF-interacting LIM domain protein, a putative nuclear translocation receptor. Mol Cell Biol 2003;23: 9025-31.
17. Coulson JM, Edgson JL, Woll PJ, Quinn JP. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker. Cancer Res 2000;60: 1840-4.
18. Shimojo M, Paquette AJ, Anderson DJ, Hersh LB. Protein kinase A regulates cholinergic gene expression in PC12 cells: REST4 silences the silencing activity of neuron-restrictive silencer factor/REST. Mol Cell Biol 1999;19:6788-95.
19. Raj B, O'Hanlon D, Vessey JP, Pan Q, Ray D, Buckley NJ, et al. Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. Mol Cell 2011;43: 843-50.
20. Calarco JA, Superina S, O'Hanlon D, Gabut M, Raj B, Pan Q, et al. Regulation of vertebrate nervous system alternative splicing and development by an SR-related protein. Cell 2009;138:898-910.
21. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8.
22. Pio R, Montuenga LM. Alternative splicing in lung cancer. J Thorac Oncol 2009;4:674-8.
23. Kreisler A, Strissel PL, Strick R, Neumann SB, Schumacher U, Becker CM. Regulation of the NRSF/REST gene by methylation and CREB affects the cellular phenotype of small-cell lung cancer. Oncogene 2010;29:5828-38.
24. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA 1990;87:6698-702.
25. Schiller JH, Jones JC. Paraneoplastic syndromes associated with lung cancer. Curr Opin Oncol 1993;5:335-42.
26. Kaiser R. Paraneoplastic neurologic syndromes. Diagnostic and pathogenetic significance of autoantibodies. Nervenarzt 1999;70: 688-701.
27. Seth KA, Majzoub JA. Repressor element silencing transcription factor/ neuron-restrictive silencing factor (REST/NRSF) can act as an enhancer as well as a repressor of corticotropin-releasing hormone gene transcription. J Biol Chem 2001;276:13917-23.
28. Kazarian M, Laird-Offringa IA. Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer 2011;10:33.
29. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999;5:662-8.
30. Moore SM, Rintoul RC, Walker TR, Chilvers ER, Haslett C, Sethi T. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway. Cancer Res 1998;58:5239-47.
31. Tsurutani J, West KA, Sayyah J, Gills JJ, Dennis PA. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy. Cancer Res 2005;65:8423-32.
32. Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y, et al. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells 2010;28:1930-9.
33. Schmid K, Bago-Horvath Z, Berger W, Haitel A, Cejka D, Werzowa J, et al. Dual inhibition of EGFR and mTOR pathways in small cell lung cancer. Br J Cancer 2010;103:622-8.
34. Tabuchi A, Yamada T, Sasagawa S, Naruse Y, Mori N, Tsuda M. REST4-mediated modulation of REST/NRSF-silencing function during BDNF gene promoter activation. Biochem Biophys Res Commun 2002;290:415-20.